OpenArc Corporate Advisory »

Allogene Therapeutics shares owned by OpenArc Corporate Advisory

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by OpenArc Corporate Advisory from 13F filings

Historical chart of OpenArc Corporate Advisory investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by OpenArc Corporate Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by OpenArc Corporate Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $420k 172k 2.44

More positions owned by OpenArc Corporate Advisory

NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Blackrock Etf Trust Ishares A I Inno (BAI)
Tcw Transform Etf Trust Transform System (PWRD)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Msci Eafe (IEFA)
Ab Active Etfs Emerging Mkts Op (EMOP)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Home Depot (HD)
Spdr Gold Tr Gold Shs (GLD)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
J P Morgan Exchange Traded F Active Value Etf (JAVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Apple (AAPL)

View all positions for OpenArc Corporate Advisory

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
Vanguard Group
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Millennium Management
Candriam Luxembourg S.C.A.
Wildcat Capital Management

View all funds holding Allogene Therapeutics